Canton Strategic Holdings (CNTN) Operating Expenses (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Operating Expenses of $36.9 million for Q1 2026, up 170.8% on a QoQ basis from $13.6 million in Q4 2025, and up 1347.71% year-over-year from $2.5 million in Q1 2025.
Canton Strategic Holdings (CNTN) Operating Expenses (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Operating Expenses history runs 6 years deep, the most recent figure standing at $36.9 million for Q1 2026.
- Quarterly Operating Expenses rose 1347.71% year-over-year to $36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (up 330.83% YoY) and the FY2025 annual result came in at $20.1 million, up 61.71% from the prior year.
- Operating Expenses was $36.9 million for Q1 2026 at Canton Strategic Holdings, up from $13.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $36.9 million in Q1 2026 and bottomed at $1.4 million in Q1 2022.
- A 5-year average of $5.0 million and a median of $2.4 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 1638.74% — and 2025, when it tumbled 45.84%.
- Canton Strategic Holdings' Operating Expenses stood at $1.8 million in 2022, then surged by 43.29% to $2.5 million in 2023, then surged by 52.0% to $3.8 million in 2024, then surged by 253.86% to $13.6 million in 2025, then jumped by 170.8% to $36.9 million in 2026.
- Business Quant data shows CNTN's Operating Expenses at $36.9 million in Q1 2026, $13.6 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.87 Mn |
| Dec 31, 2025 | 13.61 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 101,593.00 |
| Sep 30, 2021 | 541,113.00 |
| Jun 30, 2021 | 1.10 Mn |